ACBNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends March 31

AURORA CANNABIS INC

Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 40-F on Jun 11, 2026

$3.96−0.03 (-0.75%)

Close on Oct 19, 2026

AURORA CANNABIS INC income statement

Annual Quarterly TTM

CAD USD

Millions of CAD, except per-share data. Shares in millions.

Line item	FY 2026 2026-03-31	FY 2025 2025-03-31	FY 2022 2022-06-30	FY 2021 2021-06-30	FY 2020 2020-06-30	FY 2019 2019-06-30	FY 2018 2018-06-30
Revenue	321	289	221	245	269	246	55
Gross Profit	137	181	21	-22	-20	142	44
Research & Development	4.02	3.68	10	11	26	15	1.68
Selling, General & Admin	–	–	175	175	–	–	–
Selling & Marketing	60	56	62	55	90	99	29
Operating Expenses	183	171	253	261	446	461	139
Operating Income	–	4.95	-231	-283	-466	-318	-96
Interest Expense	1.81	2.52	72	66	76	39	12
Income from Equity Investments	–	–	0.29	0.51	12	9.57	-2.24
Asset Impairment Charges	–	–	5.48	–	75	89	–
Pretax Income	-57	31	-1,720	-700	-3,340	-331	77
Income Tax Expense	2.10	4.25	-2.14	-6.32	-82	-30	8.10
Income from Continuing Operations	-59	27	-1,718	-693	-3,257	-301	–
Income from Discontinued Operations	-77	-25	0	-1.61	-52	0.14	–
Net Income incl. Noncontrolling Interests	-136	1.59	-1,718	-695	-3,309	-301	69
Minority Interest in Earnings	–	–	-0.36	-1.46	–	-7.09	-2.71
Net Income	–	–	-1,718	-692	-3,283	-294	72
Net Income to Common	-122	2.27	-1,718	-694	-3,283	-294	72
EPS (Basic)(per share)	-2.14	0.04	-7.99	-4.10	-33.93	-3.66	2.03
EPS (Diluted)(per share)	-2.14	0.04	-7.99	-4.10	-33.93	-3.66	1.90
Shares Outstanding (Basic, Weighted)(shares)	57	55	215	169	97	80	36
Shares Outstanding (Diluted, Weighted)(shares)	57	56	215	169	97	80	37
EBITDA	–	7.93	-183	-234	-398	-255	-84

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Mar 31, 2026

Profitability, FY2026

Gross margin: 42.6%
Operating margin: –
Net margin: –
Return on equity, FY2026: –

Financial strength

Current ratio: 5.94
Debt to equity: 0.00
Debt to assets: 0.0%
Cash to current liabilities: 96.7%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –

Valuation ratios need the share price and fill in once daily prices are connected.